Cargando…

Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment

PURPOSE: Pancreatic cancer and its treatments impact patients’ symptoms, functioning, and quality of life. Content-valid patient-reported outcome (PRO) instruments are required to assess outcomes in clinical trials. This study aimed to: (a) conceptualise the patient experience of pancreatic cancer;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herman, Joseph M., Kitchen, Helen, Degboe, Arnold, Aldhouse, Natalie V. J., Trigg, Andrew, Hodgin, Mary, Narang, Amol, Johnson, Colin D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803577/ https://www.ncbi.nlm.nih.gov/pubmed/31273624 http://dx.doi.org/10.1007/s11136-019-02233-6

Ejemplares similares

Patients’ experience of recurrent/metastatic head and neck squamous cell carcinoma and their perspective on the EORTC QLQ-C30 and QLQ-H&N35 questionnaires: a qualitative study
por: Degboe, Arnold, et al.
Publicado: (2018)

A review of patient-reported outcome measures to assess female infertility-related quality of life
por: Kitchen, Helen, et al.
Publicado: (2017)

Patients’ Lived Experiences of Nocturia: A Qualitative Study of the Evening, the Night, and the Next Day
por: Trigg, Andrew, et al.
Publicado: (2017)

Patients’ and clinicians’ perspectives on item importance, scoring, and clinically meaningful differences for the Endometriosis Symptom Diary (ESD) and Endometriosis Impact Scale (EIS)
por: Kitchen, Helen, et al.
Publicado: (2021)

A qualitative interview study to explore adolescents’ experience of alopecia areata and the content validity of sign/symptom patient‐reported outcome measures
por: Macey, Jake, et al.
Publicado: (2022)

Healthcare Resource Utilization and Costs Associated with Ketosis Events in Pediatric and Adult Patients with Type 1 Diabetes Mellitus in the UK
por: Thalange, Nandu, et al.
Publicado: (2017)

Upfront Chemotherapy Followed by Stereotactic Body Radiation Therapy with or without Surgery in Older Patients with Localized Pancreatic Cancer: A Single Institution Experience and Review of the Literature
por: Reddy, Abhinav V., et al.
Publicado: (2022)

The Timing of Surgery Following Stereotactic Body Radiation Therapy Impacts Local Control for Borderline Resectable or Locally Advanced Pancreatic Cancer
por: Lin, Timothy, et al.
Publicado: (2023)

Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan
por: Macey, Jake, et al.
Publicado: (2021)

A comparison of three methods to generate a conceptual understanding of a disease based on the patients’ perspective
por: Humphrey, Louise, et al.
Publicado: (2017)

Development of a Conceptual Model for the Patient Experience of Focal Segmental Glomerulosclerosis (FSGS): A Qualitative Targeted Literature Review
por: Aldhouse, Natalie V. J., et al.
Publicado: (2023)

Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
por: Reddy, Abhinav V., et al.
Publicado: (2022)

Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy
por: Reddy, Abhinav V., et al.
Publicado: (2021)

Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
por: Wyrwich, Kathleen W., et al.
Publicado: (2020)

Geometric Reproducibility of Fiducial Markers and Efficacy of a Patient-Specific Margin Design Using Deep Inspiration Breath Hold for Stereotactic Body Radiation Therapy for Pancreatic Cancer
por: Han-Oh, Sarah, et al.
Publicado: (2021)

A safety study of intraoperative radiation therapy following stereotactic body radiation therapy and multi-agent chemotherapy in the treatment of localized pancreatic adenocarcinoma: study protocol of a phase I trial
por: Reddy, Abhinav V., et al.
Publicado: (2022)

Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection
por: Reddy, Abhinav V., et al.
Publicado: (2021)

Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?
por: Hill, Colin S., et al.
Publicado: (2021)

Key measurement concepts and appropriate clinical outcome assessments in pediatric achondroplasia clinical trials
por: Aldhouse, Natalie V. J., et al.
Publicado: (2022)

Inter-Breath-Hold Geometric and Dosimetric Variations in Organs at Risk during Pancreatic Stereotactic Body Radiotherapy: Implications for Adaptive Radiation Therapy
por: Hooshangnejad, Hamed, et al.
Publicado: (2023)

Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients
por: Ryan, John F., et al.
Publicado: (2018)

“‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
por: Aldhouse, Natalie V. J., et al.
Publicado: (2020)

High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy
por: Hill, Colin, et al.
Publicado: (2022)

Resectable pancreatic small cell carcinoma
por: Winter, Jordan M., et al.
Publicado: (2011)

Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
por: Hill, Colin S., et al.
Publicado: (2022)

Demonstration of Safety and Feasibility of Hydrogel Marking of the Pancreas—Duodenum Interface for Image Guided Radiation Therapy (IGRT) in a Porcine Model: Implications in IGRT for Pancreatic Cancer Patients
por: Rao, Avani D., et al.
Publicado: (2018)

Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen
por: Trigg, Andrew, et al.
Publicado: (2019)

Treatment of Leptomeningeal Carcinomatosis in a Patient with Metastatic Pancreatic Cancer: A Case Report and Review of the Literature
por: Johnson, William Rainey, et al.
Publicado: (2018)

Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer
por: Gemenetzis, Georgios, et al.
Publicado: (2021)

Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients
por: Degboe, Arnold, et al.
Publicado: (2019)

The conceptual relevance of assessment measures in patients with mild/mild-moderate Alzheimer's disease
por: Hartry, Ann, et al.
Publicado: (2018)

A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma
por: De Jesus-Acosta, Ana, et al.
Publicado: (2011)

Exploring patient perspectives on the secondary use of their personal health information: an interview study
por: Dobson, Rosie, et al.
Publicado: (2023)

The Feasibility of Haar Feature-Based Endoscopic Ultrasound Probe Tracking for Implanting Hydrogel Spacer in Radiation Therapy for Pancreatic Cancer
por: Feng, Ziwei, et al.
Publicado: (2021)

Recurrent Hypoglycaemia in a Patient with Metastatic Pancreatic Carcinoma
por: Ma, Ronald C. W, et al.
Publicado: (2006)

Altered Sphingolipid Metabolism in Patients with Metastatic Pancreatic Cancer
por: Jiang, Yixing, et al.
Publicado: (2013)

Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma
por: Park, Hyung Soon, et al.
Publicado: (2016)

Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer following Distal Pancreatectomy
por: Saif, Muhammad Wasif, et al.
Publicado: (2010)

Primary Tumor Resection for Metastatic Colorectal, Gastric and Pancreatic Cancer Patients: In Search of Scientific Evidence to Inform Clinical Practice
por: Fanotto, Valentina, et al.
Publicado: (2023)

THBS2 as a prognostic biomarker for patients diagnosed with metastatic pancreatic ductal adenocarcinoma
por: Gimotty, Phyllis A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7g1pdoughkm25d6sg9lke15na3